Optimal treatment for asymptomatic neurosyphilis

Area of Science:

• Infectious Diseases
• Neurology
• Public Health

Background:

• Asymptomatic neurosyphilis (ANS) historically carried a high risk of neurological sequelae.
• Cerebrospinal fluid (CSF) treponemicidal levels are not consistently achieved with benzathine penicillin G.
• Syphilis treatment aims to prevent neurological complications and achieve serological response.

Observation:

• A case study of a homosexual man diagnosed with asymptomatic neurosyphilis (ANS).
• The patient was successfully treated with a single dose of benzathine penicillin G.
• The patient was also co-infected with Human Immunodeficiency Virus (HIV).

Findings:

• Successful treatment of ANS with benzathine penicillin G in an HIV-positive individual.
• Observed decreased neurological complications and positive serological response post-treatment.
• The treatment regimen did not aim for sustained CSF penicillin levels.

Implications:

• Suggests benzathine penicillin G may be sufficient for treating ANS in certain populations.
• Challenges the necessity of routine lumbar puncture for HIV-infected patients with ANS.
• Highlights the importance of effective syphilis management in HIV co-infected individuals.